Cite
HARVARD Citation
Nishina, N. et al. (2013). FRI0001 Baseline soluble interleukin-6 receptor levels predict the clinical effectiveness of tocilizumab in patients with rheumatoid arthritis. Annals of the rheumatic diseases. p. A369. [Online].